EICHOR
● Completed
Methotrexate and Metformin in Rheumatoid Arthritis Patients
Condition: Arthritis, Rheumatoid · Sponsor: University Hospital, Bordeaux
About this study
Methotrexate (MTX) is the anchor drug for patients with rheumatoid arthritis (RA). Despite its marked efficacy and acceptable side effect profile, about 1/3 of patients failed to reach RA remission. Metformin is the first-line therapy for type 2 diabetes. Its antioxidative and anti-inflammatory properties make it a good candidate for the treatment of inflammatory diseases such as rheumatoid arthritis.
This description comes directly from the study's public registry record.
Talk to the study team
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
Locations (12)
| CH de la Côte Basque - service de rhumatologie | Bayonne, France | — |
| CHU de Bordeaux - service de rhumatologie | Bordeaux, France | — |
| CHU de Brest - service de rhumatologie | Brest, France | — |
| CH de Cahors - service de rhumatologie | Cahors, France | — |
| Clinique de l'Infirmerie protestante de Lyon - service de rhumatologie | Caluire-et-Cuire, France | — |
| CHD de Vendée - service de rhumatologie | La Roche-sur-Yon, France | — |
| CH du Mans - service de rhumatologie | Le Mans, France | — |
| CH de Libourne - service de rhumatologie | Libourne, France | — |
| CHU de Montpellier - service de rhumatologie | Montpellier, France | — |
| CHR Orléans la Source - service de rhumatologie | Orléans, France | — |
| CH de Pau - service de rhumatologie | Pau, France | — |
| CHU de Toulouse - service de rhumatolgie | Toulouse, France | — |
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04196868